The 1st European Market Access University Diploma: a unique and innovative course

1. The European Market Access
University Diploma
“The programme follows each step of the life cycle of a drug,
integrating market access theory and practice for results that can
be applied in the real world. Students will acquire the necessary
skills to implement and develop a market access plan”.

2. Why a Course of Market Access?
Market Access, the fourth hurdle in drug development, is today an
inescapable reality. It is a complex challenge that requires as much
knowledge as professional capability since it is situated at the crossroads
of multiple disciplines: health economics, pricing and reimbursement, risk
management and decision sciences.
To respond to the increasing demand for training in Market Access from
the healthcare sector, the first European Market Access University
Diploma (EMAUD) has been developed at the initiative of the University
of Claude Bernard Lyon 1 by Professors Mondher Toumi and Michel
Lamure with the participation of Professor Marc Bui and his team from the
Ecole Pratique des Hautes Etudes (EPHE) at Sorbonne-Paris.
University of Lyon 1, Department of Decision Sciences & Health Policy 2
Professors Mondher Toumi, Michel Lamure & Marc Bui

3. EMAUD: Unique and Innovative
The EMAUD course has been designed with industry needs top-of-mind.
The result is a ground-breaking course that offers world-class learning
experiences coupled with a wide range of expertise from institutional
organizations, the academic world and the healthcare industry.
This brand-new global course in Market Access will cover the latest topics
in the environment of health: European health policies and Market Access
current practices and future challenges.
The course follows each step of the life cycle of a drug, integrating theory
and practice. It allows the student to acquire the necessary skills to
implement a market access plan.
University of Lyon 1, Department of Decision Sciences & Health Policy 3
Professors Mondher Toumi, Michel Lamure & Marc Bui

4. What is The Objective of The Course?
Get an advanced understanding of the Market Access environment and
principles
Focus on the latest regulations and guidelines in Europe and outside
Europe
Draw a mapping of new actors : how they become inescapable decision
makers
Give techniques and tools to implement in their business
Develop knowledge in decision sciences
Allow contacts with experts from different organizations, public or private,
who are main actors in the health industry and who deal with the issues
everyday
Deliver the best practices of leading companies
University of Lyon 1, Department of Decision Sciences & Health Policy 4
Professors Mondher Toumi, Michel Lamure & Marc Bui

5. What is The Key Learning?
Set up a successful pricing and market strategy
Develop, validate and execute a market access plan
Build value story to optimize Market Access
Understand strengths and pitfalls of available evidence
Design a pricing research
Define a pricing strategy
Anticipate the future paradigm changes in Market Access
University of Lyon 1, Department of Decision Sciences & Health Policy 5
Professors Mondher Toumi, Michel Lamure & Marc Bui

6. Participants and Contributors
Participants
EMAUD is intended for students and professionals in the fields of life
science and healthcare industries.
Contributors
– European HTA and pricing agencies
– Non-Governmental agencies
– Industry key leaders
– Academics
University of Lyon 1, Department of Decision Sciences & Health Policy 6
Professors Mondher Toumi, Michel Lamure & Marc Bui

7. Duration of The Course
The course is composed of 5 modules of 4 consecutive days scheduled
during the year. Each module counts for 24 hours, which represents a total
of 120 hours for the complete course.
The 5 modules can be done separately i.e. not necessarily in only one
year, and not in any specific order.
The course is validated after the submission of a professional thesis. The
thesis could be either a company case study for professional candidates on
a study break, or a literature review for student candidates completing
their Masters or equivalent.
University of Lyon 1, Department of Decision Sciences & Health Policy 7
Professors Mondher Toumi, Michel Lamure & Marc Bui

8. Creation and Development
Pr. Mondher Toumi
University Claude Bernard Lyon 1,
Head Market Access
Pr. Michel Lamure
University Claude Bernard Lyon 1,
Head Decision Sciences & Health Policy
Pr. Marc Bui
Ecole Pratique des Hautes Etudes, Sorbonne-Paris,
Head LaISC
University of Lyon 1, Department of Decision Sciences & Health Policy 8
Professors Mondher Toumi, Michel Lamure & Marc Bui

9. Find out more at
www.EMAUD.org
University of Lyon 1, Department of Decision Sciences & Health Policy 9
Professors Mondher Toumi, Michel Lamure & Marc Bui